Skip to main content
Premium Trial:

Request an Annual Quote

Murex Licenses Ariadne's Pathway Studio for Cancer Drug Development

NEW YORK (GenomeWeb News) – Murex Pharmaceuticals licensed from Ariadne Genomics its Pathway Studio software to help develop cancer therapeutics, Ariadne said yesterday.
Murex will use Pathway Studio to develop computer-based models to identify and validate cancer targets.

Financial details were not disclosed.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.